About US
Contact us
-
Pfizer Recalling More Lipitor BottlesDrug maker Pfizer says it is recalling another 19,000 bottles of its Lipitor cholesterol medication following reports of musty odors from the bottles. The company has already pulled 370,000 Lipitor2010/12/27
-
Merck announces FDA approval for GARDASIL against HPV-related anal cancerMerck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 12010/12/24
-
Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal diseasePfizer Inc (NYSE: PFE) today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand th2010/12/24
-
Abbott and AstraZeneca End License Agreement for the Development of CertriadABBOTT PARK, Ill., Dec. 22, 2010 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today that Abbott and AstraZeneca will discontinue their joint collaboration for the development of CERTRIAD󍤚/12/23
-
American Regent initiates nationwide voluntary recall of certain lots of Dexamethasone Sodium Phosphate InjectionAmerican Regent is conducting a nationwide voluntary recall. This voluntary recall was initiated because some vials of certain lots either contain particulates or have the potential to form particu2010/12/23
-
Lilly completes acquisition of AvidEli Lilly and Company (NYSE: LLY) today announced that it has completed the acquisition of Avid Radiopharmaceuticals, Inc., a privately held company developing novel molecular imaging compounds intend2010/12/22
-
Researchers develop new malaria vaccine strategy based on ingestion of genetically modified starchThere is no efficient vaccine against malaria, although nasal and oral vaccination seems to be the most promising and suitable solution in countries where the parasite Plasmodium, which causes the dis2010/12/22
-
Novo Nordisk A/S and Emisphere Technologies, Inc. Announce License Agreement to Develop Oral Formulation of Insulin for DiabetesPRINCETON, N.J., Dec. 21, 2010 /PRNewswire/ -- Emisphere Technologies, Inc. (OTC Bulletin Board: EMIS) and Novo Nordisk A/S (NYSE: NVO) today announced that they have entered into an exclusive Develop2010/12/22
-
DNA tunneling detector embedded in a ‘Nanopore’Scientists from Imperial College London are developing technology that could ultimately sequence a person's genome in mere minutes, at a fraction of the cost of current commercial techniques. The r2010/12/21
-
FDA moves to curb Avastin's approval for breast cancerThe Food and Drug administration on Thursday revoked its approval of Roche drug Avastin for the treatment of breast cancer. The agency's action, based on findings that did not confirm that the medicin2010/12/21